Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications C Martins, F Sousa, F Araujo, B Sarmento Advanced healthcare materials 7 (1), 1701035, 2018 | 339 | 2018 |
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery JA Finbloom, F Sousa, MM Stevens, TA Desai Advanced drug delivery reviews 167, 89-108, 2020 | 155 | 2020 |
The solid progress of nanomedicine JP Martins, J Das Neves, M de la Fuente, C Celia, H Florindo, ... Drug delivery and translational research 10, 726-729, 2020 | 139 | 2020 |
Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles P Fonte, S Soares, F Sousa, A Costa, V Seabra, S Reis, B Sarmento Biomacromolecules 15 (10), 3753-3765, 2014 | 130 | 2014 |
A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles F Sousa, A Cruz, P Fonte, IM Pinto, MT Neves-Petersen, B Sarmento Scientific Reports 7 (1), 3736, 2017 | 123 | 2017 |
Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles F Sousa, HK Dhaliwal, F Gattacceca, B Sarmento, MM Amiji Journal of controlled release 309, 37-47, 2019 | 122 | 2019 |
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology RP Moura, C Martins, S Pinto, F Sousa, B Sarmento Expert opinion on drug delivery 16 (3), 271-285, 2019 | 111 | 2019 |
Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy? F Sousa, P Castro, P Fonte, PJ Kennedy, MT Neves-Petersen, ... Expert opinion on drug delivery 14 (10), 1163-1176, 2017 | 92 | 2017 |
Oral films as breakthrough tools for oral delivery of proteins/peptides PM Castro, P Fonte, F Sousa, AR Madureira, B Sarmento, ME Pintado Journal of Controlled Release 211, 63-73, 2015 | 70 | 2015 |
In situ inflammatory-regulated drug-loaded hydrogels for promoting pelvic floor repair M Qin, J Jin, Q Saiding, Y Xiang, Y Wang, F Sousa, B Sarmento, W Cui, ... Journal of Controlled Release 322, 375-389, 2020 | 67 | 2020 |
Extraction and characterisation of cellulose nanocrystals from pineapple peel AR Madureira, T Atatoprak, D Cabuk, F Sousa, RC Pullar, M Pintado International Journal of Food Studies 7 (1), 24-33, 2018 | 56 | 2018 |
How to overcome the limitations of current insulin administration with new non-invasive delivery systems F Sousa, P Castro, P Fonte, B Sarmento Therapeutic delivery 6 (1), 83-94, 2015 | 55 | 2015 |
Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6 PJ Kennedy, F Sousa, D Ferreira, C Pereira, M Nestor, C Oliveira, ... Acta biomaterialia 81, 208-218, 2018 | 45 | 2018 |
Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity F Sousa, A Cruz, IM Pinto, B Sarmento Acta Biomaterialia 78, 285-295, 2018 | 45 | 2018 |
Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery D Sgorla, A Lechanteur, A Almeida, F Sousa, E Melo, E Bunhak, ... Expert Opinion on Drug Delivery 15 (3), 213-222, 2018 | 43 | 2018 |
Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells I Pereira, F Sousa, P Kennedy, B Sarmento International journal of pharmaceutics 549 (1-2), 397-403, 2018 | 42 | 2018 |
Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules PM Castro, F Sousa, R Magalhaes, VMP Ruiz-Henestrosa, AMR Pilosof, ... Carbohydrate polymers 194, 411-421, 2018 | 39 | 2018 |
Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses F Sousa, B Sarmento, MT Neves-Petersen European Journal of Pharmaceutical Sciences 105, 127-136, 2017 | 39 | 2017 |
Chitosan-based nanomedicine for brain delivery: Where are we heading? C Pacheco, F Sousa, B Sarmento Reactive and Functional Polymers 146, 104430, 2020 | 38 | 2020 |
Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells A Baião, F Sousa, AV Oliveira, C Oliveira, B Sarmento Biomaterials Science 8 (13), 3720-3729, 2020 | 34 | 2020 |